Hypnosis for Eye Surgery

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Heidelberg University.
Recruitment status was  Recruiting
Information provided by:
Heidelberg University
ClinicalTrials.gov Identifier:
First received: September 12, 2005
Last updated: February 6, 2006
Last verified: September 2005
Perioperative stress for cataract surgery in the elderly is considerable even in the absence of pain. For these patients with a high comorbidity level, the perioperative situation comprising factors such as uncomfortable positioning, dull ambience, face cover, poor sedation, and anxiety might not only reduce intraoperative compliance but induce cardiac ischemia and hypertensive crises. Hypnosis is supposed to increase patient comfort, to shield the patient from organic stress and to improve intraoperative compliance without side effects even in old and very ill patients. In a controlled study, we, the investigators at the University of Heidelberg, compared phakoemulsification under topical anesthesia as usual (and placebo hypnosis) with either additional hypnosis or hypnoanalgesia without topical anesthesia.

Condition Intervention Phase
Procedure: Hypnoanalgesia; Hypnotic shielding
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: Correlation of Stress, Patient Comfort and Safety to Bispectral Index in Patients Under Hypnosis for Cataract Surgery

Resource links provided by NLM:

Further study details as provided by Heidelberg University:

Primary Outcome Measures:
  • Reduction of perioperative stress
  • Improvement of patient comfort and safety

Secondary Outcome Measures:
  • Correlation of hypnotic depth with bispectral index (BIS)

Estimated Enrollment: 70
Study Start Date: September 2005

Ages Eligible for Study:   10 Years to 95 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Cataract

Exclusion Criteria:

  • Uncorrected hearing disability
  • Pharmacological beta-blockade
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00176098

Contact: Thomas Frietsch, MD, PhD +49 621 383 2903 thomas.frietsch@urz.uni-heidelberg.de
Contact: Michael Schoeler, MD +49 621 383 2415 michael.schoeler@anaes.ma.uni-heidelberg.de

Dept. of Anesthesiology and Critical Care Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg Recruiting
Mannheim, Germany, 68167
Contact: Thomas Frietsch, MD, PhD    +49 621 383 2903    thomas.frietsch@urz.uni-heidelberg.de   
Sub-Investigator: Michael Schoeler, MD         
Sponsors and Collaborators
Heidelberg University
Study Chair: Thomas Frietsch, MD, PhD Dept. of Anesthesiology and Critical Care Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg
  More Information

ClinicalTrials.gov Identifier: NCT00176098     History of Changes
Other Study ID Numbers: TF-KliMa-2005-1 
Study First Received: September 12, 2005
Last Updated: February 6, 2006
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by Heidelberg University:
Cataract surgery

Additional relevant MeSH terms:
Eye Diseases
Lens Diseases

ClinicalTrials.gov processed this record on May 25, 2016